Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2004 Jul;48(7):2784; author reply 2785-6.
doi: 10.1128/AAC.48.7.2784-2786.2004.

Study design questions in treatment of children with acute otitis media

Comparative Study

Study design questions in treatment of children with acute otitis media

Alejandro Hoberman et al. Antimicrob Agents Chemother. 2004 Jul.
No abstract available

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Difference in efficacy rates between azithromycin (AZ) and amoxicillin-clavulanate (A/C) with a 95% CI for primary clinical endpoint (CE). Results are shown for children <2 years of age (<2 y/o), all children with a baseline pathogen (ME), and children <2 years of age with a baseline pathogen.

Comment on

References

    1. Arrieta, A., A. Arguedas, P. Fernandez, S. L. Block, P. Emperanza, S. L. Vargas, W. A. Erhardt, P. J. de Caprariis, and C. D. Rothermel. 2003. High-dose azithromycin versus high-dose amoxicillin-clavulanate for treatment of children with recurrent or persistent acute otitis media. Antimicrob. Agents Chemother. 47:3179-3186. - PMC - PubMed
    1. Dagan, R., C. E. Johnson, S. McLinn, N. Abughali, E. Feris, E. Leibovitz, D. J. Burch, and M. R. Jacobs. 2000. Bacteriologic and clinical efficacy of amoxicillin/clavulanate vs. azithromycin in acute otitis media. Pediatr. Infect. Dis. J. 19:95-104. - PubMed
    1. Arrieta, A., A. Arguedas, P. Fernandez, S. L. Block, P. Emperanza, S. L. Vargas, W. A. Erhardt, P. J. De Caprariis, and C. D. Rothermel. 2003. High-dose azithromycin versus high-dose amoxicillin-clavulanate for treatment of children with recurrent or persistent acute otitis media. Antimicrob. Agents Chemother. 47:3179-3186. - PMC - PubMed
    1. Blackwelder, W. C. 1995. Similarity/equivalence trials for combination vaccines. Ann. N. Y. Acad. Sci. 754:321-328. - PubMed
    1. Carlin, S. A., C. D. Marchant, P. A. Shurin, C. E. Johnson, D. M. Super, and J. M. Rehmus. 1991. Host factors and early therapeutic response in acute otitis media. J. Pediatr. 118:178-183. - PubMed

MeSH terms

Substances